Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Akasov

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Advanced Pharmaceutical Bulletin|February 6, 2018
Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D <i>in Vitro</i> ModelsRoman Akasov, Maria Drozdova, Daria Zaytseva-Zotova, et al.
ACS Nano|October 7, 2014
Biodistribution of X-ray iodinated contrast agent in nano-emulsions is controlled by the chemical nature of the oily coreMohamed F Attia, Nicolas Anton, Manuela Chiper, et al.
Dalton Transactions (Cambridge, England : 2003)|May 26, 2021
Alternative mechanism of action of the DNP Pt<sup>IV</sup> prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathwayOlga Krasnovskaya, Daniil Spector, Alexander Erofeev, et al.
Chemmedchem|January 10, 2025
Green Light Activated Dual-Action Pt(IV) Prodrug with Enhanced PDT ActivityDaniil Spector, Vladislav Bykusov, Yulia Isaeva, et al.
ACS Applied Materials & Interfaces|November 30, 2022
Radiopaque Iodosilane-Coated Lipid Hybrid Nanoparticle Contrast Agent for Dual-Modality Ultrasound and X-ray BioimagingMohamed F Attia, Roman Akasov, Nancy M Elbaz, et al.
European Journal of Pharmacology|July 14, 2020
Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro modelsNatalia M Gretskaya, Alina M Gamisonia, Polina V Dudina, et al.
ACS Applied Bio Materials|May 2, 2024
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark ToxicityDaniil Spector, Anna Bubley, Anastasia Zharova, et al.
Dalton Transactions (Cambridge, England : 2003)|May 18, 2026
Aggregation polymorphism of photoactivatable Pt(IV) prodrugs as a strategy for the design of theranostic nanomaterialsVladislav Bykusov, Ilia Kuzmichev, Maxim Stepanov, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Advanced Pharmaceutical Bulletin|February 6, 2018
Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D <i>in Vitro</i> ModelsRoman Akasov, Maria Drozdova, Daria Zaytseva-Zotova, et al.
ACS Nano|October 7, 2014
Biodistribution of X-ray iodinated contrast agent in nano-emulsions is controlled by the chemical nature of the oily coreMohamed F Attia, Nicolas Anton, Manuela Chiper, et al.
Dalton Transactions (Cambridge, England : 2003)|May 26, 2021
Alternative mechanism of action of the DNP Pt<sup>IV</sup> prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathwayOlga Krasnovskaya, Daniil Spector, Alexander Erofeev, et al.
Chemmedchem|January 10, 2025
Green Light Activated Dual-Action Pt(IV) Prodrug with Enhanced PDT ActivityDaniil Spector, Vladislav Bykusov, Yulia Isaeva, et al.
ACS Applied Materials & Interfaces|November 30, 2022
Radiopaque Iodosilane-Coated Lipid Hybrid Nanoparticle Contrast Agent for Dual-Modality Ultrasound and X-ray BioimagingMohamed F Attia, Roman Akasov, Nancy M Elbaz, et al.
European Journal of Pharmacology|July 14, 2020
Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro modelsNatalia M Gretskaya, Alina M Gamisonia, Polina V Dudina, et al.
ACS Applied Bio Materials|May 2, 2024
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark ToxicityDaniil Spector, Anna Bubley, Anastasia Zharova, et al.
Dalton Transactions (Cambridge, England : 2003)|May 18, 2026
Aggregation polymorphism of photoactivatable Pt(IV) prodrugs as a strategy for the design of theranostic nanomaterialsVladislav Bykusov, Ilia Kuzmichev, Maxim Stepanov, et al.
Pageof 3